Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics and Tolerability of Peginf-Sa in Healthy Volunteers.

Trial Profile

Pharmacokinetics and Tolerability of Peginf-Sa in Healthy Volunteers.

Phase of Trial: Phase I

Latest Information Update: 08 Oct 2014

At a glance

  • Drugs Peginterferon SA (Primary) ; Peginterferon alfa-2a
  • Indications Hepatitis B; Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 25 Mar 2013 New trial record
    • 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top